vTv Therapeutics Inc (NASDAQ: VTVT) stock suffered a major decline of -15.2% on 5/2/24. The shares closed at $23.70. However, this decline was accompanied by exceptionally low trading volume at 29% of normal. The stock has been weak relative to the market over the last nine months and has declined -7.1% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, VTVT is expected to continue to be a major Value Eraser.
vTv Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment